Selected outcome
Before Mar 1, 2027
63%
Before Mar 1, 2027 · 63%
Stored quote · checking the venue
- Scheduled end
- Dec 31, 2026 ET
- Resolution source
- U.S. Food and Drug Administration. (opens in a new tab)
Price
Loading price history.
Markets
- Before Jan 1, 2027
Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Jan 1, 2027?
23%
Open · ~$22 24h · ~$1,539 vol
Bid 22¢ · Ask 23¢
- Before Mar 1, 2027
Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Mar 1, 2027?
63%
Open · ~$6 24h · ~$2,903 vol
Bid 60¢ · Ask 65¢
- Before July 2027
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression?
84%
Open · ~$0 24h · ~$7,476 vol
Bid 81¢ · Ask 86¢
- Before October 2027
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression?
87%
Open · ~$0 24h · ~$1,932 vol
Bid 83¢ · Ask 91¢
- Before 2028
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression?
89%
Open · ~$0 24h · ~$1,022 vol
Bid 85¢ · Ask 92¢
Event statistics
How this resolves
- Scheduled end
- Dec 31, 2026 ET
- Resolution source
- Trading
- Closed
- In review
- Resolved